Report Summary
Eternity Insights has published a new study on Global NK Cell Therapy Market focusing on key segments By Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies), By Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), By Application (Cancer, Immunoproliferative Disorders, Acute Infectious Diseases, Gastrointestinal Diseases, Others), By End User (Research & Academic Institutes, Hospitals, Specialty Clinics), By Distribution Channel (Hospital Pharmacies, Direct Tender, Others), and by region. This deep dive research report highlights the market and competitive intelligence across the key segments of the market. The report also considers the impact of COVID-19 on the global NK Cell Therapy Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
NK Cell Therapy Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global NK Cell Therapy Market Size, 2018-2028 (USD Million)
To learn more about this report
Global NK Cell Therapy Market Segmentation:
NK Cell Therapy Market, By Approaches
- Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
- Bispecific Antibodies
NK Cell Therapy Market, By Therapeutics
- NK Cell Therapies
- NK Cell Directed Antibodies
NK Cell Therapy Market, By Application
- Cancer
- Immunoproliferative Disorders
- Acute Infectious Diseases
- Gastrointestinal Diseases
- Others
NK Cell Therapy Market, By End User
- Research & Academic Institutes
- Hospitals
- Specialty Clinics
NK Cell Therapy Market, By Distribution Channel
- Hospital Pharmacies
- Direct Tender
- Others
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global NK Cell Therapy market in terms of demand generation. The NK Cell Therapy market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for NK Cell Therapy market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global NK Cell Therapy Market Taxonomy:
To learn more about this report
Global NK Cell Therapy Market Competitive Landscape
The global NK Cell Therapy market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Nektar Therapeutics
- Innate Pharma SA
- Affimed
- Chipscreen Biosciences
- Fate Therapeutics
- Glycostem Therapeutics
- Dragonfly Therapeutics
- Kiadis Pharma
- NantWorks
- Nkarta Therapeutics
- Fortress Biotech
- Other Players of Specific Interest can be added based on the requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Therapeutics Outlook |
NK Cell Therapies, NK Cell Directed Antibodies |
| By Application Outlook |
Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Nektar Therapeutics, Innate Pharma SA, Affimed,Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks,Nkarta Therapeutics, Fortress Biotech |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stakeholders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global NK Cell Therapy Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 NK Cell Therapy Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 NK Cell Therapy Industry Overview
2.1 Global NK Cell Therapy Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 NK Cell Therapy Global Import Market Analysis
2.1.2 NK Cell Therapy Global Export Market Analysis
2.1.3 NK Cell Therapy Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 NK Cell Therapies
2.2.2 NK Cell Directed Antibodies
2.3.2 Gastrointestinal Diseases
2.3.3 Others
2.4.2 Global NK Cell Therapy Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global NK Cell Therapy Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 NK Cell Therapy Manufacturer Market Share
2.4.5 Top 10 NK Cell Therapy Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into NK Cell Therapy Market
2.4.7 Key Manufacturers NK Cell Therapy Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 NK Cell Therapy Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 NK Cell Therapy Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global NK Cell Therapy Market Size Categorized by Regions
4.1 Global NK Cell Therapy Revenue, Sales and Market Share by Regions
4.1.1 Global NK Cell Therapy Sales and Market Share by Regions (2015-2020)
4.1.2 Global NK Cell Therapy Revenue and Market Share by Regions (2015-2020)
4.2 Europe NK Cell Therapy Sales and Growth Rate (2015-2020)
4.3 APAC NK Cell Therapy Sales and Growth Rate (2015-2020)
4.4 North America NK Cell Therapy Sales and Growth Rate (2015-2020)
4.5 South America NK Cell Therapy Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa NK Cell Therapy Sales and Growth Rate (2015-2020)
5 Europe NK Cell Therapy Market Size Categorized by Countries
5.1 Europe NK Cell Therapy Sales, Revenue and Market Share by Countries
5.1.1 Europe NK Cell Therapy Sales by Countries (2015-2020)
5.1.2 Europe NK Cell Therapy Revenue by Countries (2015-2020)
5.1.3 Germany NK Cell Therapy Sales and Growth Rate (2015-2020)
5.1.4 UK NK Cell Therapy Sales and Growth Rate (2015-2020)
5.1.5 France NK Cell Therapy Sales and Growth Rate (2015-2020)
5.1.6 Russia NK Cell Therapy Sales and Growth Rate (2015-2020)
5.1.7 Italy NK Cell Therapy Sales and Growth Rate (2015-2020)
5.1.8 Spain NK Cell Therapy Sales and Growth Rate (2015-2020)
5.2 Europe NK Cell Therapy Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe NK Cell Therapy Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe NK Cell Therapy Sales Market Share by Type (2015-2020)
5.3.2 Europe NK Cell Therapy Revenue and Revenue Share by Type (2015-2020)
5.4 Europe NK Cell Therapy Sales Market Share by Application (2015-2020)
6 Asia-Pacific NK Cell Therapy Market Size Categorized by Countries
6.1 Asia-Pacific NK Cell Therapy Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific NK Cell Therapy Sales by Countries (2015-2020)
6.1.2 Asia-Pacific NK Cell Therapy Revenue by Countries (2015-2020)
6.1.3 China NK Cell Therapy Sales and Growth Rate (2015-2020)
6.1.4 Japan NK Cell Therapy Sales and Growth Rate (2015-2020)
6.1.5 Korea NK Cell Therapy Sales and Growth Rate (2015-2020)
6.1.6 India NK Cell Therapy Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia NK Cell Therapy Sales and Growth Rate (2015-2020)
6.1.8 Australia NK Cell Therapy Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific NK Cell Therapy Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific NK Cell Therapy Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific NK Cell Therapy Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific NK Cell Therapy Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific NK Cell Therapy Sales and Market Share by Application (2015-2020)
7 North America NK Cell Therapy Market Size Categorized by Countries
7.1 North America NK Cell Therapy Sales, Revenue and Market Share by Countries
7.1.1 North America NK Cell Therapy Sales by Countries (2015-2020)
7.1.2 North America NK Cell Therapy Revenue by Countries (2015-2020)
7.1.3 United States NK Cell Therapy Sales and Growth Rate (2015-2020)
7.1.4 Canada NK Cell Therapy Sales and Growth Rate (2015-2020)
7.1.5 Mexico NK Cell Therapy Sales and Growth Rate (2015-2020)
7.2 North America NK Cell Therapy Revenue (Value) by Manufacturers (2018-2020)
7.3 North America NK Cell Therapy Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America NK Cell Therapy Sales Market Share by Type (2015-2020)
7.3.2 North America NK Cell Therapy Revenue and Revenue Share by Type (2015-2020)
7.4 North America NK Cell Therapy Sales Market Share by Application (2015-2020)
8 South America NK Cell Therapy Market Size Categorized by Countries
8.1 South America NK Cell Therapy Sales, Revenue and Market Share by Countries
8.1.1 South America NK Cell Therapy Sales by Countries (2015-2020)
8.1.2 South America NK Cell Therapy Revenue by Countries (2015-2020)
8.1.3 Brazil NK Cell Therapy Sales and Growth Rate (2015-2020)
8.2 South America NK Cell Therapy Revenue (Value) by Manufacturers (2018-2020)
8.3 South America NK Cell Therapy Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America NK Cell Therapy Sales Market Share by Type (2015-2020)
8.3.2 South America NK Cell Therapy Revenue and Revenue Share by Type (2015-2020)
8.4 South America NK Cell Therapy Sales Market Share by Application (2015-2020)
9 Middle East and Africa NK Cell Therapy Market Size Categorized by Countries
9.1 Middle East and Africa NK Cell Therapy Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa NK Cell Therapy Sales by Countries (2015-2020)
9.1.2 Middle East and Africa NK Cell Therapy Revenue by Countries (2015-2020)
9.1.3 GCC Countries NK Cell Therapy Sales and Growth Rate (2015-2020)
9.1.4 Turkey NK Cell Therapy Sales and Growth Rate (2015-2020)
9.1.5 Egypt NK Cell Therapy Sales and Growth Rate (2015-2020)
9.1.6 South Africa NK Cell Therapy Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa NK Cell Therapy Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa NK Cell Therapy Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa NK Cell Therapy Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa NK Cell Therapy Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa NK Cell Therapy Sales Market Share by Application (2015-2020)
10 Global NK Cell Therapy Market Segment by Type
10.1 Global NK Cell Therapy Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global NK Cell Therapy Sales and Market Share by Type (2015-2020)
10.1.2 Global NK Cell Therapy Revenue and Market Share by Type (2015-2020)
10.2 NK Cell Therapies Sales Growth Rate and Price
10.2.1 Global NK Cell Therapies Sales Growth Rate (2015-2020)
10.2.2 Global NK Cell Therapies Price (2015-2020)
10.3 NK Cell Directed Antibodies Sales Growth Rate and Price
10.3.1 Global NK Cell Directed Antibodies Sales Growth Rate (2015-2020)
10.3.2 Global NK Cell Directed Antibodies Price (2015-2020)
11.1 Global NK Cell TherapySales Market Share by Application (2015-2020)
11.2 Cancer Sales Growth Rate (2015-2020)
11.3 Gastrointestinal Diseases Sales Growth Rate (2015-2020)
11.4 Others Sales Growth Rate (2015-2020)
12.1 Global NK Cell Therapy Revenue, Sales and Growth Rate (2020-2027)
12.2 NK Cell Therapy Market Forecast by Regions (2020-2027)
12.2.1 Europe NK Cell Therapy Market Forecast (2020-2027)
12.2.2 APAC NK Cell Therapy Market Forecast (2020-2027)
12.2.3 North America NK Cell Therapy Market Forecast (2020-2027)
12.2.4 South America NK Cell Therapy Market Forecast (2020-2027)
12.2.5 Middle East & Africa NK Cell Therapy Market Forecast (2020-2027)
12.3 NK Cell Therapy Market Forecast by Type (2020-2027)
12.3.1 Global NK Cell Therapy Sales Forecast by Type (2020-2027)
12.3.2 Global NK Cell Therapy Market Share Forecast by Type (2020-2027)
12.4 NK Cell Therapy Market Forecast by Application (2020-2027)
12.4.1 Global NK Cell Therapy Sales Forecast by Application (2020-2027)
12.4.2 Global NK Cell Therapy Market Share Forecast by Application (2020-2027)
13 Analysis of NK Cell Therapy Industry Key Manufacturers
13.1 Nektar Therapeutics
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Nektar Therapeutics NK Cell Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Nektar Therapeutics News
13.2 Innate Pharma SA
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Innate Pharma SA NK Cell Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Innate Pharma SA News
13.3 Affimed
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Affimed NK Cell Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Affimed News
13.4 Chipscreen Biosciences
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Chipscreen Biosciences NK Cell Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Chipscreen Biosciences News
13.5 Fate Therapeutics
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Fate Therapeutics NK Cell Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Fate Therapeutics News
13.6 Glycostem Therapeutics
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Glycostem Therapeutics NK Cell Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Glycostem Therapeutics News
13.7 Dragonfly Therapeutics
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Dragonfly Therapeutics NK Cell Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Dragonfly Therapeutics News
13.8 Kiadis Pharma
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Kiadis Pharma NK Cell Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Kiadis Pharma News
13.9 NantWorks
13.9.1 Company Details
13.9.2 Product Information
13.9.3 NantWorks NK Cell Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 NantWorks News
13.10 Nkarta Therapeutics
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Nkarta Therapeutics NK Cell Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Nkarta Therapeutics News
13.11 Fortress Biotech
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Fortress Biotech NK Cell Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 Fortress Biotech News
15 Appendix
